The 20 Best Non-Muscle Invasive Bladder Cancer Doctors Near Me in Uniondale, NY

Joph Steckel is a Urologist practicing medicine in Lake Success, New York. Dr. Steckel is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Steckel is board certified in American Board Of Urology.

Dr. Simon J Hall MD is a board certified urologist with Fellowship training in Urologic Oncology. His clinical interests include the diagnosis and treatment of Prostate, Bladder and Kidney cancers. He is especially interested in Active Surveillance of men with prostate cancer and men and women with incidentally found small renal masses and the creation of continent urinary reconstructions for patients who need to undergo cystectomy for Bladder cancer. Furthermore, Dr. Hall has a keen interest in treating patients with recurrent prostate cancer following definitive therapy. He believes that objective & balanced communication with the patient and family is the key to decision making and individualized care. Over the years Dr. Hall has been named as Best Doctor, both nationally and regionally, by organizations such as Castle Connolly, SuperDoctors and New York Magazine. Dr. Hall s research has focused of new therapies for prostate and bladder cancer; he has participated in numerous clinical trials, some of which generated data resulting in FDA approval of Sipleucel-T (Provenge) and enzulutamide (Xtandi). He oversees a laboratory investigating novel approaches to negating the Androgen Receptor, an important key driver of castration resistant prostate cancer. Decision making and improved methods of clinical care for patients with bladder and prostate cancer are important aspects of his research interests in collaboration with Dr. Michael Diefenbach, a behavioral scientist in the Departments of Urology & Medicine at NS-LIJ. He has authored or co-authored nearly 70 peer reviewed articles in Journals such as Journal of Urology, Urology, British Journal of Urology, Clinical Cancer Research and Science. Dr. Hall received his MD from the College of Physicians & Surgeons of Columbia University. He then completed two years of Surgery training at the Mount Sinai Medical Center followed by a four year residency in Urology at Boston University School of Medicine. This was followed by a 2 year fellowship in Urologic Oncology in the Scott Department of Urology at Baylor College of Medicine. Prior to joining the Smith Institute for Urology, he served on the faculty of Icahn School of Medicine at Mount Sinai for 18 years, holding various positions including Kyung Hyun Kim MD Chair of Urology and the Director of the Deane Prostate Health & Research Center. Dr. Hall is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Hall is board certified in American Board Of Urology.

"Xinhua Zhu, MD, PhD, is a medical oncologist and hematologist at Monter Cancer Center, where he specializes in treating genitourinary cancer, including cancer of the prostate, kidney, bladder and testicles. He focuses on compassionate, evidence-based care, rooted in his research background.""My research helps me think outside the box when creating treatment plans,"" says Dr. Zhu, ""and enables me to explain to patients the mechanisms behind the treatments I'm using."" His research interests include finding new treatment targets for generating hormone resistance in prostate cancer and metastatic castration-resistant prostate cancer, exploring biomarkers in bladder cancer to guide decisions about chemotherapy, exploring the mechanisms for kidney cancer metastasis, and investigating the effectiveness of immunotherapy for genitourinary cancers.Dr. Zhu earned his medical degree at Suzhou Medical College and practiced internal medicine in China. He obtained his PhD in cancer study at Shanghai Jiao Tong University School of Medicine, then moved to the United States for postdoctoral research training at Memorial Sloan Kettering Cancer Center, an internal medicine residency at Mount Sinai School of Medicine. He attended NYU School of Medicine for fellowship training in hematology and medical oncology.In 2013, he joined Northwell Health, where he regularly meets with a multidisciplinary group of pathologists, radiologists, radiation oncologists, surgical oncologists, geneticists and the Molecular Tumor Board to create treatment plans.As an associate professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, he twice received the Medical Oncology/Hematology Fellowship Program Teacher of the Year Award. Dr. Zhu is also a phase 1 cancer research program director at Monter Cancer Center. He is assistant investigator at the Feinstein Institutes for Medical Research, and a member of the American Society of Clinical Oncology, the American Association of Cancer Research, and the Principal Investigator for the Northwell Health NCI Community Oncology Research Program (NCORP)For Dr. Zhu, being able to pursue both scientific investigation and patient care is the best part of his work. ""I can take research from the bench to the bedside, providing people with the best possible treatments,"" he says.". Dr. Zhu is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, and Clear Cell Sarcoma. Dr. Zhu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Michael Shapiro is a Radiologist practicing medicine in Garden City, New York. Dr. Shapiro is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Angiomyoma, Uterine Fibroids, Thyroid Nodule, and Gallbladder Disease.

Robert Nejat is a Urologist practicing medicine in Garden City, New York. Dr. Nejat is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urothelial Cancer, Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Ureteroscopy.

Robert Moldwin, MD, FACS is Director of the Pelvic Pain Center at The Arthur Smith Institute for Urology and serves as physician-in-charge of Urologic Infectious/Inflammatory Diseases. He is Professor of Urology at the Hofstra North Shore-LIJ School of Medicine.A world-renowned leader in the field of pelvic pain, Dr. Moldwin has special interests in varied pain syndromes of the bladder and pelvis. His other clinical and research interests range from urinary incontinence to infectious diseases of the urinary tract. Dr. Moldwin is published in peer-reviewed journals including Cancer, The Journal of Urology, The British Journal of Urology International, The British Medical Journal, Contemporary Urology and Urology. Dr. Moldwin is an expert consultant, lecturing to audiences of physicians, patients, and members of the media on issues such as incontinence, urological health, interstitial cystitis, and pelvic disorders. He currently serves on multiple medical advisory boards, including the Interstitial Cystitis Association, and has been a member of their Board of Directors for over a decade.Dr Moldwin is affiliated with numerous medical societies including the American Urological Association, International Association for the Study of Pain and The Society for Female Urology and Urodynamics. He is past president of the Society for Infections and Inflammation in Urology. He was also co-chairperson for the recently completed Multidisciplinary Approaches to the Study of Chronic Urologic Pelvic Pain (MAPP), a research initiative sponsored by the National Institutes of Health. Dr Moldwin is currently a committee reviewer for the American Urological Association IC/BPS Guidelines and serves as Vice-President for the International Society for the Study of Interstitial Cystitis/Bladder Pain Syndrome (ESSIC).After earning his medical degree at the University of Chicago Pritzker School of Medicine, Dr. Moldwin completed his general surgical training and urology residency at the Long Island Jewish Medical Center. He also served as a Valentine Fellow through the New York Academy of Medicine, studying infectious and inflammatory urological diseases in the Department of Urology at Thomas Jefferson Medical College in Philadelphia. Dr. Moldwin is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Interstitial Cystitis, Bacterial Prostatitis, Frequent or Urgent Urination, and Vulvodynia. Dr. Moldwin is board certified in American Board Of Urology.

Dr. Rofeim joined the medical staff of the Smith Institute for Urology and the Hofstra NS-LIJ School of Medicine in July 2012 after being in private practice in the New York area for 10 years. After completion of general surgery training at LIJ and Beth Israel Medical Centers, he continued with urology residency at LIJ Medical Center where he served as the chief resident under the mentorship of Drs. Arthur Smith and Gopal Badlani. He graduated magna cum laude from CUNY-Queens College and cum laude from SUNY-Downstate Medical Center.During his undergraduate training, he won numerous awards including the Donald E. Lancefield Prize, the Howard Hughes Summer Fellowship Award for undergraduate research, the Robert Keating Memorial Award and was included in the National Dean's List. He received the prestigious American Medical Association Physician Recognition Award and AUA/Praecis Gerald P. Murphy Scholar Award for Distinction in the study of prostate cancer. During his residency training, he won the Academic Annual Research Competition at LIJ Medical Center.He is a member of the Alpha Omega Alpha Medical Honor Society where he served as the vice president, the American Urologic Society and the New York Section of the American Urologic Society. Dr. Rofeim is a diplomate of the American Board of Urology (Board certified) and a fellow of the American College of Surgeons. He has published several articles and a book chapter in the fileds of fertility and incontinence and has presented numerous abstracts at the American Urologic Association annual meetings and other prestigious societies in topics of fertility and interstitial cystitis. Interests include:Enlarged ProstateErectile DysfunctionGeneral UrologyIncontinenceKidney StonesUrologic Cancers. Dr. Rofeim is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Diphallia, Enlarged Prostate (BPH), and Ureteroscopy. Dr. Rofeim is board certified in American Board Of Urology.

Gideon Richards is a Urologist practicing medicine in Garden City, New York. Dr. Richards is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Bilateral Hydronephrosis, Hydronephrosis, Obstructive Uropathy, Ureteroscopy, and Nephrectomy. Dr. Richards is board certified in American Board Of Urology.

Dr. Adam Cole is a board-certified urologist. He is an attending urologist at the Smith Institute for Urology at Northwell Health, Associate Residency Program Director and an Assistant Professor of Urology at the Zucker School of Medicine at Hofstra University. A native of Michigan, Dr. Cole completed medical school and urology residency at University of Michigan Medical Center in Ann Arbor, Michigan. He has clinical expertise in prostate cancer detection, treatment of enlarged prostate (BPH), and kidney stones, and treats a wide breadth of urologic diseases and conditions. He has over 20 scientific publications and has received grants for research. He has received multiple awards for clinical care and research, including Michigan Medicine's Making a Difference Award,University of Michigan's James B. Angell Scholar designation, and Academy of Academic Surgeon's Outstanding Medical Student award.Dr. Cole sees patients at the Smith Institute for Urology offices at Garden City and Great Neck, and operates at North Shore University Hospital in Manhasset. He lives on Long Island with his wife and two children. Dr. Cole is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His clinical expertise encompasses UPJ Obstruction, Malakoplakia, Obstructive Uropathy, Prostatectomy, and Ureteroscopy. Dr. Cole is board certified in American Board Of Urology.

Anthony Corcoran is an Oncologist practicing medicine in Garden City, New York. Dr. Corcoran is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Vasectomy.

Louis Faiella is a Urologist practicing medicine in Garden City, New York. Dr. Faiella is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Boils, and Ureteroscopy.

Mario Lacouture is a Dermatologist practicing medicine in Garden City, New York. Dr. Lacouture is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Autosomal Recessive Hypotrichosis, Hartsfield Syndrome, Alopecia Areata, and Basal Cell Skin Cancer.

Gary Lefkowitz is a Urologist practicing medicine in Rockville Centre, New York. Dr. Lefkowitz is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Hydronephrosis, Bilateral Hydronephrosis, Obstructive Uropathy, Ureteroscopy, and Prostatectomy.

Corinne Liu is a Radiologist practicing medicine in Mineola, New York. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Metastatic Pleural Tumor, Lung Nodules, and Lymphofollicular Hyperplasia.

Kai Tsao, MD, MS, is the system chief of solid tumor oncology, medical director of the R.J. Zuckerberg Cancer Center, and medical director of the medical oncology prostate cancer program at the Northwell Cancer Institute. He specializes in cancers of the genitourinary organs and has more than a decade of clinical experience. His research focuses on the development of biomarkers and novel therapies for patients with genitourinary cancers.Dr. Tsao was inspired to become an oncologist after witnessing many close family and friends suffering from cancer. He completed medical school training at SUNY Downstate, an internal medicine residency at Long Island Jewish Medical Center, and a fellowship in hematology and medical oncology at Mount Sinai Hospital. He earned a master's degree in healthcare delivery leadership at Icahn School of Medicine at Mount Sinai and completed Lean Six Sigma training at Johns Hopkins.Prior to joining Northwell, Dr. Tsao served as medical director of the Ruttenberg Treatment Center, medical director of the medical oncology prostate cancer program, and physician leader for internal oncology collaborations at the Mount Sinai Hospital, Tisch Cancer Institute. In these roles, Dr. Tsao and his team built a cancer center that is patient centered, quality driven, scientifically innovative, and provided multi-disciplinary care to patients with cancer.For me, patient care much more than the cancer diagnosis and treatment. It is essential to address the many needs of our cancer patients: emotional well-being, social support, nutrition, physical activity, financial challenges and more. We aim to provide the best support for our patients, one at a time.Dr. Tsao is an accomplished physician-scientist who has authored more than 80 peer-reviewed publications in the field of genitourinary oncology. He serves as associate editor of Genitourinary Oncology, Frontiers in Oncology. His leadership in carrying out complex clinical trials in targeted therapies and immunotherapies positions his patients at the forefront of cutting-edge cancer research and patient-centered care.What I most enjoy every day is seeing patients under our care, despite the devastation of their cancer diagnosis, beating their cancer and living a life that was not considered a possibility years ago. Our mission at Northwell Cancer Institute is to make this a reality for every single patient. Dr. Tsao is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Orchiectomy, and Nephrectomy. Dr. Tsao is board certified in American Board Of Internal Medicine/Medical Oncology.

Gary Goldberg is a Urologist practicing medicine in Manhasset, New York. Dr. Goldberg is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Ureteroscopy, and Reconstructive Urology Surgery. Dr. Goldberg is board certified in American Board Of Urology.

Gary Oshinsky is a Urologist practicing medicine in Garden City, New York. Dr. Oshinsky is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, Male Pseudohermaphroditism with Gynecomastia, and Ureteroscopy.

Andrew Choi is a Radiologist practicing medicine in Mineola, New York. Dr. Choi is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Breast Lump, Galactocoele, Lymphoid Hyperplasia, and WT1-Related Wilms Tumor Syndromes.

Nicholas Georgiou is a Radiologist practicing medicine in Mineola, New York. Dr. Georgiou is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Ascites, Lung Cancer, EGFR Positive Lung Cancer, Bone Marrow Aspiration, and Endoscopy.

Michael J. Drabkin, MD is the Chief of Interventional Radiology at NY Imaging / New York Cancer & Blood Specialists (NYCBS), serving Long Island and the greater New York City area. He is board-certified in both Diagnostic Radiology and Interventional Radiology.His practice focuses on minimally invasive, same-day treatments for enlarged prostate (BPH), uterine fibroids, varicoceles, and cancer. Dr. Drabkin performs more than 650 Prostate Artery Embolizations (PAE) per year, placing him among the highest-volume PAE physicians in the United States. He has performed over 20,000 image-guided procedures during his career.He completed his fellowship in Vascular and Interventional Radiology at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, where he served as Chief Fellow. He earned his undergraduate degree at Columbia University and his medical degree from SUNY Upstate Medical University.Dr. Drabkin is a Castle Connolly Top Doctor, and an active member of the Society of Interventional Radiology and the American Urological Association. He is well published in professional journals, and has been an invited speaker at national and international conferences. Dr. Drabkin is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Ascites, Familial Colorectal Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Liver Embolization. Dr. Drabkin is board certified in Interventional Radiology and Diagnostic Radiology. Dr. Drabkin is currently accepting new patients.